Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2025-12-25 @ 12:40 AM
NCT ID: NCT00611767
Eligibility Criteria: Inclusion Criteria: 1. Male and female between the ages of 21 and 30 years 2. medically and neurologically healthy on the basis of history, physical examination, Electrocardiogram (EKG), screening laboratories 3. absence of any evidence of substance abuse (with the exception of nicotine dependence) on the basis of history and drug and ethanol-free at the time of testing based on urine toxicology and breath alcohol levels at screening and on each test day. Exclusion Criteria: 1. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) Axis I psychiatric and substance abuse or dependence diagnosis by history on psychiatric evaluation that includes a structured diagnostic interview (SCID) 2. unwillingness to remain alcohol-free for three days prior to each test day; 3. for women, positive pregnancy test at screening or intention to engage in unprotected sex during the study and 4. alcohol naive. For Family History Positive Subjects: 1) Biological father and another first or second-degree biological relative with history of alcoholism by Family History Assessment Module (FHAM) developed by The Collaborative Study on the Genetics of Alcoholism (COGA). For Family History Negative Subjects: NO family history of alcoholism in any first or second-degree relatives. Subjects must reliably report on three first-degree relatives.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 21 Years
Maximum Age: 30 Years
Study: NCT00611767
Study Brief:
Protocol Section: NCT00611767